1.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: AAO-101, NCT00466388
|
|
2.
|
Phase: Phase IV Type: Behavioral study, Supportive care Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: #5996, NCT01191580
|
|
3.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 21 and over Sponsor: Other Protocol IDs: 110032, NCT01385488
|
|
4.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 110806, NCT01625455
|
|
5.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: KELD-ESS-0413, NCT01861717
|
|
6.
|
Phase: Phase III, Phase II Type: Behavioral study, Biomarker/Laboratory analysis, Supportive care Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: BRS0008, K07CA132916-01A1, 25740, NCT01011218
|
|
7.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: OmegaDVS, NCT01803711
|
|
8.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: CDR0000365458, FCCC-03028, NCT00084552
|
|
9.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 3 to 21 at diagnosis Sponsor: NCI, Other Protocol IDs: ACNS0331, COG-ACNS0331, CDR0000365506, NCT00085735
|
|
10.
|
Phase: Phase III Type: Supportive care Status: Approved-not yet active Age: Adult Sponsor: Other Protocol IDs: 04-005, NCT00201630
|
|
11.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000499633, NCCTG-N0574, ACOSOG-N0574, N0574, NCT00377156
|
|
12.
|
Phase: Phase III Type: Supportive care Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2007-0302, NCT00561444
|
|
13.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000582632, EORTC-26053, CAN-NCIC-CEC1, RTOG-0834, EORTC-22054, EUDRACT-2006-001533-17, SPRI-EORTC-26053, MERCK-EORTC-26053, MRC-BR14, COGNO-EORTC-26053, CEC1, NCT00626990
|
|
14.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: UCCO08106; URCC0701, U10CA037420, UCCO-08106, URCC 0701, URCC-O08106, NCT00924651
|
|
15.
|
Phase: Phase III Type: Educational/Counseling/Training, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Pro00009040, 1P01NR010948-01, NCT00938769
|
|
16.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000654697, ECOG-E3F05, E3F05, NCT00978458
|
|
17.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000654709, RTOG-0724, NCT00980954
|
|
18.
|
Phase: Phase III Type: Supportive care Status: Active Age: Not specified Sponsor: NCI, Other Protocol IDs: 2327.00, NCI-2010-00323, P01CA018029, NCT00929695
|
|
19.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 1 to < 10 Sponsor: NCI, Other Protocol IDs: AALL0932, COG-AALL0932, CDR0000683227, NCI-2011-02599, NCT01190930
|
|
20.
|
Phase: Phase III Type: Supportive care, Tissue collection/Repository Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000684240, NCCTG-N08C9, N08C9, NCT01198145
|
|
21.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2009-0976, NCT01202851
|
|
22.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2010-0584, NCT01266044
|
|
23.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GWCA0999, 2009-016529-32, NCT01337089
|
|
24.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-034, NCT01355926
|
|
25.
|
Phase: Phase III Type: Health services research, Supportive care Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: 1R01CA127493-01A2, NCT01365182
|